Aladdin Healthcare Technologies Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Wade Menpes-Smith
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 14.8% |
| Management average tenure | no data |
| Board average tenure | 4yrs |
Recent management updates
Recent updates
CEO
Wade Menpes-Smith
no data
Tenure
Mr. Wade Menpes-Smith serves as Chief Executive Officer, Managing Director & Chairman of the Board of Directors at Aladdin Healthcare Technologies SE (formerly known as Aladdin Blockchain Technologies Hold...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | no data | no data | 14.8% € 39.9k | |
| Deputy Chairman & COO | no data | no data | no data | |
| CFO & Director | 2.2yrs | no data | no data | |
| Member of Drug Discovery Advisory Board & Chief Scientific Advisor | 2.3yrs | no data | no data | |
| Member of Early Diagnosis Advisory Board & Adviser of Early Stage Drug Discovery | 4yrs | no data | no data | |
| Member of Drug Advisory Board & Adviser of Neurological Research | 4yrs | no data | no data | |
| Member of Early Diagnosis Advisory Board & Adviser of Aging | 4yrs | no data | no data | |
| Member of Early Diagnosis Advisory Board & Adviser of Biological Research | 4yrs | no data | no data | |
| Member of Drug Advisory Board & Adviser of Cardiovascular | 4yrs | no data | no data | |
| Member of Drug Discovery Advisory Board & Adviser of Medical Imaging | 4yrs | no data | no data | |
| Member of Drug Discovery Advisory Board & Adviser of Biobank | 3.1yrs | no data | no data |
4.0yrs
Average Tenure
Experienced Board: NMI's board of directors are considered experienced (4 years average tenure).